Jean-Francois H. Geschwind MD, Presenter: Grant, Boston Scientific Corporation Grant, Genentech, Inc Grant, Biocompatibles International plc Grant, MDS Inc Consultant, Biocompatibles International plc Consultant, MDS Inc Consultant, Terumo Corporation Consultant, BioSphere Medical, Inc Patent holder, 3-BrPa for Targeting Tumor Metabolism

Michael Choti MD, Presenter: Nothing to Disclose

1) To understand the available choices for patient management of hepatocellular carcinoma, including resection, transplantation, and ablation, intraarterial and systemic approaches. 2) To interpret the most recent data regarding the efficacy of each of these modalities in the context of case management. 3) To understand the controversies regarding indications and contraindications, and how to individualize recommended therapies based on specific case scenarios.

 

Geschwind, J, Choti, M, Hepatocellular Carcinoma: Patient Management Algorithms.  Radiological Society of North America 2008 Scientific Assembly and Annual Meeting, February 18 - February 20, 2008 ,Chicago IL. http://archive.rsna.org/2008/6007094.html